CNL Cleco Corp.

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 28, 2008

CLECO CORPORATION

(Exact name of registrant as specified in its charter)

Louisiana		1-15759		72-1445282
(State or other jurisdiction		(Commission File Number)		(IRS Employer
of incorporation)				Identification No.)

2030 Donahue Ferry Road
Pineville, Louisiana		71360-5226
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: ( 318) 484-7400

CLECO POWER LLC

(Exact name of registrant as specified in its charter)

Louisiana		1-05663		72-0244480
(State or other jurisdiction		(Commission File Number)		(IRS Employer
of incorporation)				Identification No.)

2030 Donahue Ferry Road
Pineville, Louisiana		71360-5226
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: ( 318) 484-7400

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 1.01 Entry into a Material Definitive Agreement.

     On May 28, 2008, Cleco Power LLC (the “Company”), a wholly owned subsidiary of Cleco Corporation, entered into an Underwriting Agreement (the “Underwriting Agreement”) with BNY Mellon Capital Markets, LLC, Calyon Securities (USA) Inc. and KeyBanc Capital Markets Inc. (collectively, the “Underwriters”) covering the issue and sale of $250,000,000 aggregate principal amount of the Company’s 6.65% Notes due 2018 (the “Notes”). The Notes mature on June 15, 2018. The offer and sale of the Notes are registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the shelf registration statement (Registration No.333-132832) of the Company, as supplemented by the Prospectus Supplement dated May 28, 2008 relating to the Notes filed with the Securities and Exchange Commission pursuant to Rule 424(b) of the Securities Act. Affiliates of the Underwriters are lenders under the Company’s $275 million five-year credit facility.

     Closing of the issuance and sale of the Notes is scheduled for June 3, 2008 and is subject to customary conditions contained in the Underwriting Agreement.

     The Underwriters have agreed in the Underwriting Agreement to purchase all of the Notes if any of them are purchased. If an Underwriter defaults, the agreement provides that the purchase commitment of the nondefaulting underwriter may be increased or the agreement may be terminated. The Company has agreed in the Underwriting Agreement to indemnify the Underwriters against certain liabilities, including liabilities under the Securites Act, or to contribute to payments the Underwriters may be required to make in respect of those liabilities.

Item 9.01 Financial Statements and Exhibits.

          (c) Exhibits.

          The following exhibits are furnished herewith:

	1.1		Underwriting Agreement dated May 28, 2008 by and between the Company and the Underwriters.
	4.1		Form of Ninth Supplemental Indenture providing for the issuance of the Notes.
	4.2		Form of Note (included in Exhibit 4.1 above).
	5.1		Opinion of Baker Botts L.L.P.

SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

EXHIBIT INDEX

Exhibit Number		Exhibit Description
1.1		Underwriting Agreement dated May 28, 2008 by and between the Company and the Underwriters.
4.1		Form of Ninth Supplemental Indenture providing for the issuance of the Notes.
4.2		Form of Note (included in Exhibit 4.1 above).
5.1		Opinion of Baker Botts L.L.P.

Cleco (NYSE:CNL)
Historical Stock Chart
From May 2024 to Jun 2024

Cleco (NYSE:CNL)
Historical Stock Chart
From Jun 2023 to Jun 2024